BioNexus Gene Lab Corp Quarterly Common Stock, Shares, Issued from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
BioNexus Gene Lab Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2018 to Q4 2023.
  • BioNexus Gene Lab Corp Common Stock, Shares, Issued for the quarter ending December 31, 2023 was 17.7M shares, a 22% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 17.7M +3.19M +22% Dec 31, 2023 10-K 2024-04-16
Q2 2023 174M +2.5M +1.46% Jun 30, 2023 10-Q 2023-08-16
Q1 2023 174M +2.5M +1.46% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 14.5M -157M -91.5% Dec 31, 2022 10-K 2024-04-16
Q3 2022 174M +2.5M +1.46% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 171M 0 0% Jun 30, 2022 10-Q 2023-08-16
Q1 2022 171M 0 0% Mar 31, 2022 10-Q 2023-05-09
Q4 2021 171M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 171M +68.5M +66.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 171M +68.5M +66.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 171M +68.5M +66.7% Mar 31, 2021 10-Q 2021-05-18
Q4 2020 171M +68.5M +66.7% Dec 31, 2020 10-K 2022-04-06
Q3 2020 103M +29M +39.4% Sep 30, 2020 10-Q/A 2020-11-09
Q2 2020 103M +28.1M +37.7% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 103M Mar 31, 2020 10-Q 2020-05-08
Q4 2019 103M +28.1M +37.7% Dec 31, 2019 10-K 2021-03-30
Q3 2019 73.7M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 74.6M Jun 30, 2019 10-Q 2019-08-09
Q4 2018 74.6M Dec 31, 2018 10-K 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.